TCR2 Therapeutics Inc is a biotechnology company based in Cambridge, MA. Specializing in the field of immuno-oncology, the company focuses on developing novel T cell therapies for the treatment of cancer.
Through innovative research and cutting-edge technology, TCR2 Therapeutics Inc aims to harness the power of the immune system to target and eliminate cancer cells, ultimately improving patient outcomes in the fight against cancer.
Generated from their business information